GeneDx Launches Prenatal Noonan Test on MiSeq; Adds Mito Genome to Exome Test, Plans Focused Version | GenomeWeb

GeneDx has launched a prenatal Noonan syndrome spectrum test that runs on Illumina's MiSeq, taking advantage of the platform's short turnaround time, and is planning additional prenatal next-gen sequencing panels. Also, the company recently released an expanded version of its diagnostic whole-exome sequencing test that includes the mitochondrial genome and plans to offer a focused version of the test that only analyzes a small subset of the genes.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In PNAS this week: map of UV-induced damage in yeast genome, comparative epigenomics uncovers plant lacking key DNA methyltransferase enzyme, and more.

Researchers kick off their second Queer in STEM survey to examine what can make STEM careers welcoming, Wired reports.

A startup company is offering a test to analyze soil samples from farms for pathogens.

Prosecutors seek to introduce evidence from low-template DNA analysis in a murder case in upstate New York, the New York Times reports.